search
Back to results

EuroPainClinics® Study II (Prospective Trial) (EPCSII)

Primary Purpose

Lumbar Spinal Stenosis

Status
Completed
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Epiduroscopy
Hyaluronic Acid
DepoMedrol
Sponsored by
Europainclinics z.ú.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lumbar Spinal Stenosis focused on measuring Epiduroscopy,, Failed back surgery syndrome, Spinal Stenosis with neurologic changes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age of 18 years or older
  • Written informed consent
  • Patients with FBSS
  • Magnetic resonance examination evidence of intervertebral disc herniation
  • Permanent pain radiating to lower limbs despite previous periradicular therapy or caudal block
  • Actual Magnetic resonance imaging: lesion without serious spinal stenosis, lesion without serious radicular compression, lesion without serious intervertebral disc herniation

Exclusion Criteria:

  • Patients not capable of consenting
  • Pregnant women or women of child-bearing potential
  • Cauda equine syndrome

Sites / Locations

  • Czech republic

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Other

Experimental

Other

Experimental

Arm Label

Epiduroscopy mechanical lysis - failed back surgery syndrome

Epiduroscopy combination - failed back surgery syndrome

Epiduroscopy mechanical lysis - chronic low back pain without previous spine surgery

Epiduroscopy combination - chronic low back pain without previous spine surgery

Arm Description

Epiduroscopy only mechanical lysis

Epiduroscopy together mechanical lysis of epidural adhesions together with epidural drug administration Hyaluronic acid 150 IU and Depo-Medrol 80mg

Epiduroscopy only mechanical lysis

Epiduroscopy together mechanical lysis of epidural adhesions together with epidural drug administration Hyaluronic acid 150 IU and Depo-Medrol 80mg

Outcomes

Primary Outcome Measures

Pain as assessed by the Visual analogue scale
All acquired information will be noted in to the special anonymous protocol

Secondary Outcome Measures

Pain progress as assessed by global pain scale
All acquired information will be noted in to the special anonymous protocol
Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids
All acquired information will be noted in to the special anonymous protocol
Pain localization as assessed by note of radiating dermatome as neurologic examination
All acquired information will be noted in to the special anonymous protocol

Full Information

First Posted
May 26, 2015
Last Updated
December 30, 2021
Sponsor
Europainclinics z.ú.
search

1. Study Identification

Unique Protocol Identification Number
NCT02459392
Brief Title
EuroPainClinics® Study II (Prospective Trial)
Acronym
EPCSII
Official Title
EuroPainClinics® Study II (Prospective Randomized Double Blinded Trial)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
December 31, 2021 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Europainclinics z.ú.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In this prospective multi-centre double-blind trial the effect of the epiduroscopy will be examined in (approximately 300) adult patients with low back pain pain caused by failed back surgery syndrome (FBSS).
Detailed Description
A small flexible fibreoptic catheter is inserted in sacral hiatus and the areas of concern can be visualized on the screen. Effective drugs like active enzyme: Hyaluronic acid and corticosteroids then can be injected through the same catheter. With this method we can eliminate adhesions or scar tissue that may be pulling or irritating specific nerve roots. Indicated for this procedure are patients with low back pain or sciatic patients who have not had a successful result with back surgery or spine surgery and have experienced continued pain after surgery: Failed back surgery syndrome (FBSS). Trial will compare groups of patients after fulfilment inclusion with Failed back surgery syndrome who will undergo interventional pain release procedure epiduroscopy. Elimination of adhesions, or scar tissue will be provided mechanically (grabbers, balloon techniques, by radiofrequency or laser) and with medical support (Hyaluronic acid and Depo-Medrol administration via epidural catheter). The first group of patients enrolled in to the trial will undergo only mechanical lysis of epidural adhesions (grabbers, balloon techniques, by radiofrequency or laser). The second group of patients enrolled in to the trial will undergo mechanical lysis of epidural adhesions together with epidural drug administration (Hyaluronic acid 150 IU and Depo-Medrol 80mg). After first visit in ambulance patients will be about study informed. After agreement patient will be in to the study involved. Specific unique nine digits number will be assigned to each patient. Then patients will be randomized in to groups by special evaluated software created especially for this study. Patients will agree that about range of epiduroscopy (mechanical or combination of mechanical and drug administration) will be informed until the end of the study. This way will be patients blinded All acquired information will be noted in to the special anonymous protocol. Also patients will anonymously fulfill Oswestry Low Back Disability Questionnaire EQ-5D-5LQuestionnaire) . Second examination will be provided after 6 months. Patients will be in the beginning introduced to doctor only by their unique number. Doctor will be blinded and he will not dispose with information about microinvasive procedure and will examine patient. Data which will be collected: (Visual analogue scale, dermatome where pain is radiating, global pain scale, changes in analgesics drugs consumption). All acquired information will be noted in to the special anonymous protocol. Also patients will anonymously fulfill Oswestry Low Back Disability Questionnaire EQ-5D-5LQuestionnaire) . The third examination will be provided after 12 months same way. Patients will be in the beginning introduced to doctor only by their unique number. Doctor will be blinded and he will not dispose with information about microinvasive procedure and will examine patient. Data which will be collected: (Visual analogue scale, pain radiating dermatome, global pain scale, changes in analgesics drugs consumption). All acquired information will be noted in to the special anonymous protocol. Also patients will anonymously fulfill Oswestry Low Back Disability Questionnaire, EQ-5D-5LQuestionnaire).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Spinal Stenosis
Keywords
Epiduroscopy,, Failed back surgery syndrome, Spinal Stenosis with neurologic changes

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
300 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Epiduroscopy mechanical lysis - failed back surgery syndrome
Arm Type
Other
Arm Description
Epiduroscopy only mechanical lysis
Arm Title
Epiduroscopy combination - failed back surgery syndrome
Arm Type
Experimental
Arm Description
Epiduroscopy together mechanical lysis of epidural adhesions together with epidural drug administration Hyaluronic acid 150 IU and Depo-Medrol 80mg
Arm Title
Epiduroscopy mechanical lysis - chronic low back pain without previous spine surgery
Arm Type
Other
Arm Description
Epiduroscopy only mechanical lysis
Arm Title
Epiduroscopy combination - chronic low back pain without previous spine surgery
Arm Type
Experimental
Arm Description
Epiduroscopy together mechanical lysis of epidural adhesions together with epidural drug administration Hyaluronic acid 150 IU and Depo-Medrol 80mg
Intervention Type
Other
Intervention Name(s)
Epiduroscopy
Intervention Description
Epiduroscopy has two main uses in the pain clinic: Releasing epidural adhesions for the relief of chronic sciatica. Adhesions can form around the lower lumbar nerve roots after decompressive surgery for disc disease or after a bad bout of inflammatory sciatica in the absence of surgery. Epidural adhesions can usually be identified on an enhanced magnetic resonance scan using intravenous gadolinium. They also cause uneven spread of X-ray contrast when performing an epidurogram. Injecting mixtures of local anesthetic and depot steroid around inflamed nerve roots when epidural injections / nerve root blocks have been unsuccessful. The presence of adhesions can prevent epidurally injected drugs from reaching the inflamed nerve roots.
Intervention Type
Drug
Intervention Name(s)
Hyaluronic Acid
Intervention Description
Drug administration
Intervention Type
Drug
Intervention Name(s)
DepoMedrol
Intervention Description
Drug administration
Primary Outcome Measure Information:
Title
Pain as assessed by the Visual analogue scale
Description
All acquired information will be noted in to the special anonymous protocol
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Pain progress as assessed by global pain scale
Description
All acquired information will be noted in to the special anonymous protocol
Time Frame
3 years
Title
Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids
Description
All acquired information will be noted in to the special anonymous protocol
Time Frame
3 years
Title
Pain localization as assessed by note of radiating dermatome as neurologic examination
Description
All acquired information will be noted in to the special anonymous protocol
Time Frame
3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age of 18 years or older Written informed consent Patients with FBSS Magnetic resonance examination evidence of intervertebral disc herniation Permanent pain radiating to lower limbs despite previous periradicular therapy or caudal block Actual Magnetic resonance imaging: lesion without serious spinal stenosis, lesion without serious radicular compression, lesion without serious intervertebral disc herniation Exclusion Criteria: Patients not capable of consenting Pregnant women or women of child-bearing potential Cauda equine syndrome
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juraj Mláka, MD PhD
Organizational Affiliation
R-Clinic
Official's Role
Study Chair
Facility Information:
Facility Name
Czech republic
City
Praha
Country
Czechia

12. IPD Sharing Statement

Learn more about this trial

EuroPainClinics® Study II (Prospective Trial)

We'll reach out to this number within 24 hrs